Moleculin Biotech (NASDAQ:MBRX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Moleculin Biotech (MBRX) operate in?

Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Moleculin Biotech Stock (NASDAQ: MBRX) stock price, news, charts, stock research, profile.

Open	$2.64
Close	$2.83
Volume / Avg.	19.41K / 42.04K
Day Range	$2.63 - $2.84
52 Wk Range	2.12 - 15.75
Market Cap	$8.50M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	4.22%
Days to Cover	6.02

Recent News

Micron, Signet Jewelers And 3 Stocks To Watch Heading Into Wednesday

With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Avi Kapoor

Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38%

Moleculin Biotech Inc (NASDAQ: MBRX) provided a preliminary update on recent clinical activity from annamycin

Vandana Singh

Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.64
Close	$2.83
Volume / Avg.	19.41K / 42.04K
Day Range	$2.63 - $2.84
52 Wk Range	2.12 - 15.75
Market Cap	$8.50M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	4.22%
Days to Cover	6.02

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Moleculin Biotech (MBRX) stock?

You can purchase shares of Moleculin Biotech (NASDAQ:MBRX) through any online brokerage.

View our list of the best stock brokerages

Who are Moleculin Biotech (MBRX) competitors?

Other companies in Moleculin Biotech’s space includes: Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), T2 Biosystems (NASDAQ:TTOO) and Addex Therapeutics (NASDAQ:ADXN).

What is the forecast, or price target, for Moleculin Biotech (MBRX) stock?

Moleculin Biotech has a consensus price target of $14.00.

What is the current price for Moleculin Biotech (MBRX)?

The stock price for Moleculin Biotech (NASDAQ: MBRX) is $2.83 last updated November 21, 2024 at 5:20 PM EST.

Does Moleculin Biotech (MBRX) pay a dividend?

There are no upcoming dividends for Moleculin Biotech.

When is Moleculin Biotech (NASDAQ:MBRX) reporting earnings?

Moleculin Biotech’s Q3 earnings are confirmed for Friday, November 8, 2024.

Is Moleculin Biotech (MBRX) going to split?

There is no upcoming split for Moleculin Biotech.

What sector and industry does Moleculin Biotech (MBRX) operate in?

Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Moleculin Biotech

Moleculin Biotech (MBRX) Forecast